# Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

> **NCT06325501** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 56 (estimated)

## Conditions studied

- Myoma;Uterus

## Interventions

- **DRUG:** Misoprostol 200mcg Tab
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT06325501
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06325501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06325501, "Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06325501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*